Suspensory Ligament Release: What Surgery Won’t Tell You

Introduction: The One Fact Surgical Pages Don’t Lead With

Once the suspensory ligament is cut, it cannot be reattached. That single sentence should sit at the top of every consultation, every brochure, and every surgical webpage, because it defines the entire decision. This is not a reversible cosmetic tweak. It is a permanent, structural change to load-bearing anatomy.

Men researching this topic are typically not casual browsers. They have already searched the clinical term. They are professionals accustomed to evaluating evidence before making high-stakes decisions, and they are applying that same rigor to a deeply personal one. They deserve to be treated accordingly.

This article does not argue against enhancement. It argues for complete information. The marketing around suspensory ligament release emphasizes flaccid length gains and “permanent results.” The peer-reviewed data tells a more complicated story: a 35% satisfaction rate, near-zero erect length gain, and outcomes that remain genuinely unpredictable.

What follows is straightforward: what the suspensory ligament actually does, what the surgery actually changes, what the outcome data actually shows, and what the evidence-supported alternative looks like.

What the Suspensory Ligament Actually Does (And Why That Matters)

The penile suspensory ligament (PSL) is a fibrous, triangular structure that anchors the penis to the pubic symphysis. Its function is stabilization. It holds the penis in position during erection and maintains the upward penopubic angle that makes penetrative intercourse mechanically reliable.

This is functional, load-bearing tissue, not passive anatomy. The characteristic upward angle of an erection and much of its positional rigidity during intercourse depend on this ligament. Patient-facing references such as Cleveland Clinic’s anatomy resource note that injuries to this ligament, though rare, can cause pain or changes in erection angle.

There is a natural clinical analog worth understanding. Men born without a functional suspensory ligament experience an inability to maintain sexual intercourse due to slippage of the erect penis. That is the natural consequence of losing the very structure that surgery intentionally severs.

One clarification matters: the ligament does not limit the length of erectile tissue. The internal penile shaft (the corpora) extends into the pelvis whether the ligament is intact or not. Understanding this distinction is essential to evaluating what the surgery actually achieves and what it permanently sacrifices.

What Suspensory Ligament Release Surgery Actually Does

Ligamentolysis, or suspensory ligament release, is the surgical detachment of the PSL from the pubic symphysis. Cutting it allows more of the internal shaft to hang externally.

What it does not do is increase corporal length. Anatomical research published by the American Urological Association in 2024 confirmed that PSL division “provides the illusion of a longer penis, despite corporal length remaining the same.” The internal shaft that appears externally after surgery was always there; it has simply been repositioned.

In plain terms, the primary benefit is cosmetic and flaccid-only. Realistic flaccid gains are modest, averaging 1 to 3 cm (roughly 0.4 to 1.2 inches). One peer-reviewed study of 42 patients reported a mean stretched length increase of just 1.3 ± 0.9 cm, with a range from -1 to +3 cm. Some patients ended up shorter.

Erect length gains are minimal to none. The ligament’s structural role diminishes during full erection when tissues are engorged, meaning the procedure’s main cosmetic effect largely disappears in the state that matters most.

Despite this, ligamentolysis is the default option, used in roughly 83% of penile lengthening surgical cases. It is therefore the option most men encounter first when researching surgery.

There is also a compliance burden that is rarely disclosed upfront. To prevent the ligament from reattaching and negating any gains, patients must wear a penile traction device for months after surgery. That is a significant, sustained obligation, not a footnote.

The Data Surgical Pages Bury: Satisfaction, Outcomes, and Variability

The headline number is striking: overall patient satisfaction after suspensory ligament release is only 35%. Nearly two out of three men who undergo this irreversible procedure are not satisfied with the outcome.

This is not an outlier finding. Broader literature places patient and partner satisfaction rates at 30 to 65% across multiple peer-reviewed reviews. The 35% figure sits squarely within that range.

The subgroup data is more sobering. Satisfaction drops to 27% in patients with penile dysmorphic disorder (PDD). Research shows that 64% of surgical candidates in one cohort carried PDD as a preoperative diagnosis, meaning the majority of men seeking this surgery fall into the subgroup with the lowest satisfaction.

Unpredictability compounds the problem. A 2024 study in Aesthetic Plastic Surgery confirmed that outcomes “exhibit substantial variability and remain challenging to predict,” with no validated preoperative method to anticipate individual results. There is no reliable way to know in advance whether a patient lands in the satisfied 35% or the dissatisfied 65%.

A 2024 systematic review in Medicina covering 46 studies concluded that the risks and complexities of surgical penile augmentation “must be carefully accounted for.” The Sexual Medicine Society of North America (SMSNA) issued a formal 2024 position statement in the Journal of Sexual Medicine addressing suspensory ligament division, prioritizing patient safety and transparent counseling. A critical analysis in European Urology went further, concluding that penile enhancement procedures “lack standardization, have poorly defined outcomes, carry unacceptably high complication rates, and should be regarded as investigational.”

The Complication Profile: What Permanent Consequences Look Like

These are not theoretical risks. They are documented outcomes from peer-reviewed complication series and referral-center data.

The primary documented complications include:

• Downward-pointing or unstable erections (penile instability and drooping)
• Scarring and scar deformation
• Wound breakdown
• Infection
• Damage to the dorsal neurovascular bundle
• Altered penile sensation
• Erectile dysfunction

The erection angle change deserves emphasis because it is a structural consequence, not a rare misfortune. The natural upward angle frequently becomes horizontal or downward-pointing after surgery, mirroring the clinical presentation of congenital PSL deficiency, the same condition that causes an inability to maintain intercourse.

A referral-center complication series published in the Journal of Urology is instructive. Among 12 men who presented with complications from suspensory ligament release, only 1 reported a subjective length increase, 6 required reoperation, and 4 reported sexual dysfunction.

Reattachment (recurrence) presents an additional concern: the ligament heals back, negating gains and potentially causing net shortening. This is precisely why surgeons now often place a silicone buffer in the gap, adding procedural complexity to prevent the tissue from doing what it naturally attempts to do.

Many surgical complications can be corrected. The loss of suspensory ligament structural support cannot. Any resulting instability or angle change may be permanent or require further corrective surgery with its own risk profile. This is not a well-standardized, outcome-proven intervention; major medical bodies still consider it experimental.

The Psychological Dimension: Why Surgery Often Doesn’t Solve the Underlying Problem

Penile dysmorphic disorder (PDD) is a clinical reality, not a judgment. It is a subtype of body dysmorphic disorder in which penis size or shape becomes the primary preoccupation, with recognized diagnostic criteria.

The prevalence is significant. In one cohort, 64% of surgical candidates carried PDD as a preoperative diagnosis, meaning most men seeking this surgery have a condition for which surgery is not the evidence-supported treatment.

The reason surgery does not resolve PDD is straightforward: the distress is not caused by objective dimensions, so changing those dimensions does not address the root condition. This is precisely why the PDD subgroup reports a 27% satisfaction rate even when the surgery technically “works.” A 2025/2026 study from Tehran University of Medical Sciences noted that small penis anxiety and PDD “can lead to dissatisfaction even in those with normal-sized penises.”

Research on motivation reframes the conversation. Men’s primary reason for seeking penile augmentation is to improve self-confidence, not to achieve an objective size change. That finding opens the door to alternatives that address confidence more directly.

Identifying whether PDD is a factor helps ensure a man pursues the path most likely to achieve his actual goal (confidence and sexual satisfaction) rather than an irreversible procedure with a 65% dissatisfaction rate. Psychological screening before surgery is a clinical imperative recommended by the SMSNA; its absence from a surgical consultation is itself a red flag.

What the Evidence Actually Supports: Non-Surgical Girth Enhancement

Most men researching suspensory ligament release want meaningful, lasting improvement with minimal risk. The evidence suggests non-surgical girth enhancement delivers on that goal more reliably than surgical lengthening.

Hyaluronic acid (HA) filler for penile girth is the evidence-supported alternative. A retrospective study of nearly 500 men found HA filler appeared safe with limited adverse events, no reports of erectile dysfunction or penile sensation loss, and all adverse events resolved with conservative measures.

A prospective, blinded, randomized, multicenter trial found HA filler produced mean girth increases of 2.1 ± 1.0 cm with significantly increased patient satisfaction at 24 weeks and no significant impact on erectile function (IIEF-5 scores). Broader data shows mean flaccid girth increases of approximately 2.5 cm (range 1.5 to 4 cm), a visible change affecting both flaccid and erect states.

The reversibility advantage is decisive. HA filler can be dissolved with hyaluronidase if a patient is unsatisfied, a fundamental safety edge over an irreversible surgery with a 65% dissatisfaction rate. A 2024 Journal of Sexual Medicine study concluded that HA dermal filler injection is “an effective option for men desiring non-surgical penile girth enhancement.”

There is also a clinically meaningful point regarding relevance: research consistently shows that girth, not length, is the dimension most associated with sexual satisfaction for both partners, making penis girth vs. length enhancement the more pertinent consideration for the goal most men actually have.

Why Girth Enhancement Addresses What Men Actually Want

The research on motivation (confidence and sexual satisfaction) aligns directly with what girth enhancement delivers: visible improvement in both flaccid and erect states, partner-reported satisfaction, and restored confidence without permanent structural compromise.

Contrasting the outcome profiles clarifies the distinction:

• Suspensory ligament release: 35% satisfaction, near-zero erect gain, permanent irreversibility, documented erection instability.
• HA filler girth enhancement: multicenter trial satisfaction data, 2.1 cm mean girth increase, reversible, no erectile dysfunction reported.

On the question of permanence, HA filler does require maintenance, with longevity averaging 18 to 24 months. Advanced collagen-stimulating protocols, however, yield 80 to 90% permanent improvement in girth and volume. The ability to maintain, adjust, or reverse results is a feature, not a limitation.

Girth enhancement also meaningfully affects the erect state, unlike ligament release, which primarily changes flaccid appearance. For men whose real goal is confidence and sexual satisfaction, the evidence-supported path is the one with higher satisfaction rates, lower complication rates, and the option to reverse if needed.

The Stoller Medical Group Approach: Non-Surgical Girth Enhancement in Practice

Stoller Medical Group, operating as Penis Enlargement New York City, has made a deliberate, safety-based decision not to offer surgical penile lengthening. That clinical position is consistent with the evidence reviewed here.

The procedure is non-surgical filler phalloplasty using medical-grade, biocompatible collagen-stimulating dermal filler placed beneath the penile skin to enhance girth and volume. It is an outpatient treatment completed in under one hour, with no cutting and no general anesthesia.

Results include up to 1 to 1.5 inches in girth increase, with 80 to 90% permanent improvement in girth and volume, visible immediately and maintained in both flaccid and erect states.

On pricing: the procedure starts at $7,500 and increases based on desired results. Pricing is by syringe; most men start with a minimum of 10 syringes and average 15 syringes during their first procedure. A free consultation establishes the individualized treatment plan.

Experience matters when precision placement in vascular anatomy is the technical challenge. The practice has performed over 15,000 enlargement procedures. Recovery is efficient: patients are back on their feet in 10 days (compared to 40-plus days with other permanent filler options), with sexual activity resumable within 7 to 10 days.

The staged treatment approach uses incremental sessions rather than single dramatic procedures, allowing for symmetry optimization and risk reduction. Five locations (Manhattan, Long Island, Albany, Pennsylvania, and Minnesota) and free consultations make the process accessible.

How to Evaluate Your Options: A Framework for High-Stakes Medical Decisions

Before any irreversible procedure, the following questions merit careful consideration.

1. What does the procedure actually change? Distinguish flaccid appearance, erect length, and girth, and identify which aligns with the actual goal.
2. What does the outcome data show? Not marketing claims, but peer-reviewed satisfaction rates, complication rates, and variability data from independent studies.
3. What are the permanent consequences of a poor outcome? For ligament release: erection instability, altered angle, potential sexual dysfunction, with no path to reversal.
4. Is there a reversible alternative with comparable or superior data? For girth enhancement, yes: HA filler with multicenter trial support, reversibility, and no erectile dysfunction reported.

A fifth consideration is equally important: psychological screening. If size preoccupation is causing significant distress independent of objective measurements, addressing that dimension first (or concurrently) produces better long-term outcomes than surgery alone.

This framework is empowerment, not gatekeeping. The goal is to ensure any decision is made with complete information rather than the selective disclosure that characterizes most surgical marketing.

Frequently Asked Questions

Does suspensory ligament release increase erect length?
No. The AUA’s 2024 anatomical research confirmed PSL division “provides the illusion of a longer penis, despite corporal length remaining the same.” Erect length gains are minimal to none.

Can the suspensory ligament be reattached if results are unsatisfactory?
No. Once cut, it cannot be reattached. Any resulting instability or erection angle changes may be permanent or require additional corrective surgery.

What is the actual satisfaction rate for suspensory ligament release?
35% overall in the key peer-reviewed study, dropping to 27% in men with penile dysmorphic disorder, who represent the majority of surgical candidates.

How does non-surgical girth enhancement compare to surgical lengthening in terms of satisfaction?
A prospective multicenter trial showed significantly increased satisfaction at 24 weeks with HA filler girth enhancement, with no erectile dysfunction reported, representing a meaningfully different outcome profile.

Is penile filler enhancement permanent?
Advanced collagen-stimulating protocols produce 80 to 90% permanent improvement in girth and volume, with results lasting 18 to 24 months and optional maintenance sessions available. Unlike surgery, results can be adjusted or reversed. Learn more about penile dermal filler permanence rates and what to expect long-term.

How much does non-surgical girth enhancement cost?
At Stoller Medical Group, the procedure starts at $7,500 and increases based on desired results. Pricing is by syringe; most men start with a minimum of 10 syringes and average 15 syringes during their first procedure. A free consultation establishes the individualized plan.

Who is a good candidate for non-surgical girth enhancement?
Generally healthy men with realistic expectations seeking moderate, natural-looking enhancement, particularly those who want visible improvement in both flaccid and erect states without the permanent structural risks of surgery.

Conclusion: The Decision Is Permanent; The Information Doesn’t Have to Be Incomplete

Suspensory ligament release is an irreversible procedure with a 35% satisfaction rate, near-zero erect length gain, documented erection instability, and no validated method to predict individual outcomes. These are not arguments against enhancement. They are the facts a thoughtful man deserves before making a permanent decision.

The goal itself is entirely legitimate. Wanting to feel more confident, more satisfied, and more capable in intimate contexts is reasonable. The only real question is which path gets there most reliably with the least permanent risk.

Non-surgical girth enhancement with HA filler delivers multicenter trial-supported satisfaction improvements, meaningful girth increases in both flaccid and erect states, no reported erectile dysfunction, and the option to reverse. That is a risk-adjusted outcome profile surgical lengthening cannot match.

The men most likely to achieve lasting confidence and genuine improvement are those who choose the path supported by evidence rather than the one supported by marketing.

Take the Next Step: Schedule Your Free Consultation

A free consultation at Stoller Medical Group includes an individualized anatomy assessment, realistic goal-setting, a transparent discussion of expected outcomes and longevity, and a customized treatment plan, with no pressure and no commitment.

The practice does not offer surgical penile lengthening, a deliberate clinical decision that reflects the same evidence-based philosophy this article represents. With over 15,000 procedures performed across five locations by Dr. Roy B. Stoller and his team, and 25-plus years in aesthetic and restorative medicine, that experience is grounded in precision and patient safety.

Five locations make the process accessible:

• Manhattan: 515 Madison Avenue, Suite 1205
• Long Island: Jericho
• Albany: Latham
• Pennsylvania: Chadds Ford
• Minnesota: Eagan

A free consultation is the logical next step for a man who has done his research and is ready to discuss his options with a qualified specialist. The goal is meaningful, lasting improvement, and that starts with the right conversation.